Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VER-01 in Chronic Non-specific Low Back Pain
NCT06475001Phase 2Completed
- Sponsor
- Vertanical
- Start
- Jun 2024
- Primary completion
- Jul 2025
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of VER-01 in Low back pain (LBP) (5 arms), sponsored by Vertanical. Primary endpoint: Efficacy based on pain reduction at Week 7. Started Jun 2024; status: completed.
02
Drugs
VER-01
03
Conditions
Low back pain (LBP)
Beyond the preview
Go deeper on NCT06475001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06475001.